Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Depressive state and regional cerebral activity in cancer patients - a preliminary study.

Manabu Tashiro, Freimut D Juengling, Michael J Reinhardt, Michael Mix, Hiroaki Kumano, Kazuo Kubota, Masatoshi Itoh, Hidetada Sasaki, Egbert U Nitzsche, Ernst Moser

Med Sci Monit 2001; 7(4): CR687-695 :: ID: 421084

Abstract

BACKGROUND: The aim of this study was to investigate influences of depressivestates, chemotherapy and existence of remaining tumors on the regional brain activity of cancer patients.
MATERIAL AND METHODS: Positron emission tomography with 18F-fluorodeoxyglucose was performed on 21 patientswith various types of cancer. Their brain images were compared to 10 age- and gender-matched controldata using statistical parametric mapping (SPM). The patients were subgrouped into the with and withoutdepression based on the scores on Zung's self-rating depression scale (SDS), with and without previouschemotherapy, and with and without existence of remaining tumors.
RESULTS: Significant metabolic reductionwas detected in the cingulate gyrus, prefrontal, dorsolateral prefrontal, temporoparietal cortices andbasal ganglia in cancer patients. These findings were close to known lesions of major depression. Intra-groupcomparisons showed that these hypometabolic findings were associated with the depth of depressive state.Influences of chemotherapy and remaining tumors on the cerebral cortex seemed to be weaker than thatof psychological factors.
CONCLUSIONS: The present pilot study suggests that frontal hypoactivity commonlyseen in cancer patients is likely to be associated with depression rather than chemotherapy or remainingtumors. A brain mapping technique might be useful in evaluating neuropsychiatric problems in cancer patients.

Keywords: PET, cerebral glucose metabolism, cancer patient, Depression, chemotherapy, paraneoplastic factor

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750